Tumor cells release EV PD-L1, which can interact with PD-1 on the surface of T cells, thereby inhibiting their effector function and reducing the release of the pro-inflammatory cytokines IFN-γ, IL-2, and granzyme-b. The gene discussed is IFNG; the disease is neoplasm.